Objective:

To evaluate the efficacy and risk profile of cysto-ventricular catheter (CVC) placement in patients with glioma and intracranial metastasis, focusing on specific risks associated with the procedure.

Key Findings:

• CVC placement was effective in reducing cyst volume and improving symptoms in patients with glioma and brain metastasis, with a notable percentage of patients reporting symptom relief.
• Cyst progression-free survival was achieved in a significant number of patients post-surgery, indicating the procedure's effectiveness.
• The technique demonstrated a favorable safety profile with minimal complications, suggesting its viability as a treatment option.

Interpretation:

CVC implantation appears to be a viable treatment option for managing symptomatic cysts associated with gliomas and brain metastases, providing symptom relief and reducing cyst size effectively.

Limitations:

• Retrospective design may introduce selection bias, affecting the reliability of the findings.
• Limited sample size may affect the generalizability of the findings to a broader population.
• Lack of long-term follow-up data on cyst recurrence and patient outcomes limits the understanding of the procedure's long-term efficacy.

Conclusion:

CVC placement is a promising intervention for patients with space-occupying cysts due to glioma and brain metastasis, offering effective symptom management and cyst volume reduction, which could significantly impact clinical practice.